Literature DB >> 9463638

Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.

D E Newby1, S Masumori, N R Johnston, N A Boon, D J Webb.   

Abstract

OBJECTIVE: Both endothelin-1 and nitric oxide make important contributions to the maintenance of basal peripheral arteriolar tone. However, the role of angiotensin II, a key hormone regulating cardiovascular and renal function, in the regulation of peripheral vascular tone has not been fully characterised.
METHODS: Using local intra-arterial administration of losartan, a selective angiotensin II type 1 (AT1) receptor antagonist, we examined the contribution of endogenous angiotensin II to the maintenance of basal and sympathetically stimulated vascular tone in the forearm of healthy man under conditions of sodium repletion and depletion. The effects of losartan on responses to exogenous angiotensin I, angiotensin II, bradykinin and noradrenaline were also determined.
RESULTS: Losartan, in keeping with its actions as a selective AT1 receptor antagonist, inhibited responses to angiotensin I and II, but had no effect on responses to bradykinin or noradrenaline. The dose of angiotensin II required to cause a 20% vasoconstriction was 40- and 250-fold greater with 30 and 300 micrograms/min of losartan, respectively. However, in sodium replete subjects, losartan alone caused no significant changes in basal forearm blood flow (95% confidence interval of -7.2 to +8.0%), forearm vascular resistance or sympathetically stimulated forearm vasoconstriction. Sodium depletion elevated plasma renin activity and angiotensin II concentrations (p < or = 0.002) after which acute local administration of losartan increased forearm blood flow in a dose dependent manner (maximum of 69 +/- 17%; p < 0.001).
CONCLUSIONS: Endogenous angiotensin II does not contribute to the acute local maintenance of basal peripheral vascular tone in healthy man except under conditions of renin-angiotensin system activation such as sodium depletion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9463638     DOI: 10.1016/s0008-6363(97)00171-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  4 in total

Review 1.  The acute vascular effects of frusemide in heart failure.

Authors:  P S Jhund; J J McMurray; A P Davie
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

2.  Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

3.  Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.

Authors:  Manuel Haschke; Manfred Schuster; Marko Poglitsch; Hans Loibner; Marc Salzberg; Marcel Bruggisser; Joseph Penninger; Stephan Krähenbühl
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

4.  Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.

Authors:  D E Newby; N E Goodfield; A D Flapan; N A Boon; K A Fox; D J Webb
Journal:  Heart       Date:  1998-08       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.